News

After a rocky start to the year, health insurer stocks have roared back. The insurers are trying to end a difficult cycle that began about three years ago, when healthcare use, and the costs to cover it, accelerated postpandemic. The fund’s top 10 holdings encompass six health insurers, three of which— UnitedHealth Group Aetna parent CVS Health and Elevance Health —comprise more than 40% of the fund.

You don't need to predict a recession to prepare your portfolio. These two stocks can help.

BKD's Q2 weighted average occupancy rises to 82.4% as steady resident demand and RevPAR growth expectations set the stage for its upcoming earnings.

CVS Health is scheduled to post its second-quarter results in August, and analysts project a single-digit earnings rise.

The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.

Plus, two hotel management companies merged, and a real estate investment firm nabbed an eight-property portfolio.

The settlement could be the end of a long legal saga for Omnicare, which filed for bankruptcy last year after a judge ordered the company to pay nearly $950 million for fraudulently billing government health programs.

Choice Hotels International (NYSE:CHH) has appointed Ali Keshavarz, CVS Health's President and Chief Data & Analytics Officer, to its Board. The company is also undergoing changes across several indices, including removals from certain value and small or mid cap benchmarks. At the same time, Choice Hotels has been added to the Russell 1000 Dynamic Index. Choice Hotels International enters this news cycle with its stock trading at $109.61 and a mixed return profile. The shares are up 14.1%...

In the closing of the recent trading day, CVS Health (CVS) stood at $102.81, denoting a -1.59% move from the preceding trading day.

Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”

David Joyner’s assurances, which come about a month before CVS is scheduled to report its second quarter results, will likely be welcomed by investors wary after a difficult few years for insurers.

The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.

While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.

While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.

Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.

The S&P 500 keeps climbing, up nearly 9% year to date, and yet a handful of large-cap dividend payers are trading like the bull market forgot they exist. That is exactly where opportunity hides in July. If you have $1,000 to put to work, three NYSE-listed names stand out on valuation, cash flow, and payout ... 3 Absurdly Cheap Dividend Stocks to Buy With $1,000 in July

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

The Pacer US Cash Cows 100 ETF (CBOE:COWZ) is having a solid 2026, up 6.4% year to date and 14.81% over the past year through July 6. Yet a fund built expressly to own America’s biggest cash machines holds zero shares of Apple, arguably the most famous cash generator on the planet. That contradiction is ... Up 14.81% in a Year, COWZ Proves You Don’t Need Apple

CVS Health (NYSE:CVS) agreed to a multi million dollar settlement over alleged false Medicaid and government program claims tied to insulin pen dispensing between 2010 and 2020. The company also received court approval to sell its Omnicare long term care pharmacy business to GenieRx, advancing a planned exit from that segment. These developments affect CVS Health’s regulatory risk profile and the future shape of its pharmacy and health services operations. CVS Health sits at the...

Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

THC is gaining on rising admissions, strong ambulatory care growth and earnings momentum. But can it sustain gains as expenses keep climbing?

UnitedHealth posted a higher net income margin last quarter, while both companies saw their revenue growth pause after a long expansion.

We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Pharmaceutical retailer CVS Health Corporation (NYSE:CVS) has become one of Cramer’s top stocks in the sector. Throughout this year, the CNBC TV […]

CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]

ELV seeks to recover an estimated $115 million through a CMS lawsuit over Medicare Advantage Star Ratings and disputed bonus payments.

Vltava Fund, a value-focused investment management company, published its investor letter for the second quarter of 2026. A copy of the letter can be downloaded here. The letter explores the growing role of AI and how certain facets of human intelligence may become less valuable economically, while other skills become more important. The author emphasizes […]

ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.

While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.

Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.